Advertisement
Singapore markets close in 2 hours 33 minutes

  • Straits Times Index

    3,434.18
    +18.67 (+0.55%)
     

  • Nikkei

    40,913.65
    +332.89 (+0.82%)
     

  • Hang Seng

    17,997.55
    +18.98 (+0.11%)
     

  • FTSE 100

    8,171.12
    +49.92 (+0.61%)
     

  • Bitcoin USD

    58,698.23
    -2,351.57 (-3.85%)
     

  • CMC Crypto 200

    1,232.65
    -28.54 (-2.26%)
     

  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     

  • Dow

    39,308.00
    -23.90 (-0.06%)
     

  • Nasdaq

    18,188.30
    +159.54 (+0.88%)
     

  • Gold

    2,369.40
    0.00 (0.00%)
     

  • Crude Oil

    83.35
    -0.53 (-0.63%)
     

  • 10-Yr Bond

    4.3550
    -0.0810 (-1.83%)
     

  • FTSE Bursa Malaysia

    1,617.71
    +2.39 (+0.15%)
     

  • Jakarta Composite Index

    7,240.76
    +44.01 (+0.61%)
     

  • PSE Index

    6,502.64
    +52.61 (+0.82%)
     

DMK Pharmaceuticals: Q3 Earnings Snapshot

Associated Press Finance
·1-min read

SAN DIEGO (AP) — SAN DIEGO (AP) — DMK Pharmaceuticals Corporation (DMK) on Tuesday reported a loss of $1.4 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 20 cents. Losses, adjusted to account for discontinued operations, came to 25 cents per share.

The biopharmaceutical company posted revenue of $9,100 in the period. Its adjusted revenue was $9,000.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DMK at https://www.zacks.com/ap/DMK